Treosulfan Completed Phase 2 Trials for Leukemia Acute Myeloid Leukemia (AML) Supportive Care

IndicationsStatusPurposePhase
CompletedSupportive Care2
clinicaltrials.gov IdentifierTitleDrugs
NCT01063660Treosulfan Based Conditioning Acute Myeloid Leukaemia (AML)